EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) shares traded up 75.7% during trading on Thursday . The stock traded as high as $0.14 and last traded at $0.14. 103 shares were traded during trading, a decline of 97% from the average session volume of 3,429 shares. The stock had previously closed at $0.08.
EOM Pharmaceuticals Stock Up 75.7 %
The company has a 50 day moving average of $0.15 and a 200 day moving average of $0.18.
EOM Pharmaceuticals Company Profile
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
Featured Articles
- Five stocks we like better than EOM Pharmaceuticals
- Market Cap Calculator: How to Calculate Market Cap
- 3 Leveraged ETFs to Multiply Returns
- Dividend Payout Ratio Calculator
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Investing in Travel Stocks Benefits
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
